S

Spaarne Gasthuis | Haarlem Zuid - Cardiology

Research site
(Unclaimed)
Location
Boerhaavelaan 22, Haarlem, Noord-Holland, Netherlands

Site insights

Top conditions

Top treatments

Upadacitinib
Bococizumab
Ribociclib
Durvalumab
Morphine
Olaparib
Sunitinib
Bevacizumab
panitumumab
Atezolizumab

Parent organization

This site is a part of Spaarne Gasthuis

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

9 of 51 total trials

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL (EPCORE DLBCL-1)

The purpose of this trial is to find out if epcoritamab, also known as EPKINLY™ and GEN3013, is safe and works well as treatment for patients with di...

Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Investigator's Choice Chemotherapy
Biological: Epcoritamab

This study will test the hypothesis that implantation of a subcutaneous implantable cardioverter defibrillator (S-ICD) without performing a defibrill...

Active, not recruiting
Ventricular Arrythmia
Procedure: ommitence of defibrillation testing

The purpose of the study is to evaluate the effect of olezarsen on percent change in fasting triglyceride (TG) levels compared to placebo in particip...

Active, not recruiting
Hypertriglyceridemia
Cardiovascular Diseases
Drug: Placebo
Drug: Olezarsen

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). The purpose of t...

Enrolling
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab
Drug: Rituximab

The study is non-randomized, multicenter international safety, performance and clinical benefit outcome assessment of ANEUFIX to treat patients with...

Enrolling
Endoleak
Abdominal Aortic Aneurysm
Device: ANEUFIX

Digoxin is the oldest, market-authorized drug for heart failure (HF), and very cheap. A large trial with digoxin, the DIG trial, executed in the earl...

Active, not recruiting
Heart Failure
Drug: Digoxin
Drug: Placebos

The aim of this prospective, randomized, multicenter, open-label, phase II study is to test if chemotherapy can be replaced by the combination of rib...

Active, not recruiting
Breast Neoplasms
Drug: Chemotherapy
Drug: Letrozole

This is a prospective, non-randomized clinical trial that aims to describe the efficacy and toxicity of commercially available, targeted anticancer d...

Enrolling
Tumors
Neoplasm
Drug: Tepotinib
Drug: Axitinib

Trial sponsors

Erasmus University logo
Maastricht University Medical Centre (MUMC) logo
A
AbbVie logo
D
R
Genmab logo
I
Netherlands Cancer Institute (NKI) logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems